HETEROCYCLES, Vol. 78, No. 4, 2009
981
4.53 (s, 2 H, CH), 1.69-1.43(m, 10H, CH2); Anal. Calcd for C12H13N3O2: C, 62.33; H, 5.67; N, 18.17.
Found: C, 62.41; H, 5.60; N, 19.21.
7,11-Dicyano 3-Oxa-9-azaspiro[5.5]undecane-8,10-dione (4f) : mp 196-198oC. IR (KBr) ν: 3234 (NH),
2219 (CN), 1734, 1705 (C=O) 1185 (C-O) cm-1; 1H NMR (DMSO-d6, 400 MHz) δ: 12.10 (s, 1 H, NH),
4.92 (s, 2 H, CH), 3.72-3.66 (m, 4 H, OCH2),1.72-1.68 (m, 4H, CH2); Anal. Calcd for C11H11N3O3: C,
56.65; H, 4.76; N, 18.02. Found: C, 56.45; H, 4.68; N, 18.15.
4-Phenyl-3,5-dicyano-2,6-piperidinedione (4g) : mp 248-249oC (lit.,1 mp 255oC); IR (KBr) ν: 3305
1
(NH), 2260 (CN), 1712, 1692 (C=O) cm-1; H NMR (DMSO-d6, 400 MHz) δ: 12.02 (s, 1 H, NH),
7.45-7.32 (m, 5 H, ArH), 4.96-4.87 (m, 2 H, CH), 4.40-4.32 (m, 1 H, CH); Anal. Calcd for C13H9N3O2: C,
52.79; H, 5.64; N, 22.39. Found: C, 52.65; H, 5.58; N, 22.35.
4-(4-Fluorophenyl)-3,5-dicyano-2,6-piperidinedione (4h) : mp 245-247oC (lit.,1 mp 255oC); IR (KBr)
ν: 3315 (NH), 2274 (CN), 1726, 1702 (C=O) cm-1; 1H NMR (DMSO-d6, 400 MHz) δ: 12.08 (s, 1 H, NH),
7.20-6.92(m, 4 H, ArH), 4.73-4.69 (m, 2 H, CH), 4.34-4.28 (m, 1 H, CH); Anal. Calcd for C13H8FN3O2:
C, 60.70; H, 3.13; N, 16.33. Found: C, 60.45; H, 3.15; N, 16.20.
4-(4-Methoxyphenyl)-3,5-dicyano-2,6-piperidinedione (4i) : mp 317-318oC (lit.,1 mp 325oC); IR (KBr)
ν: 3294 (NH), 2256 (CN), 1736, 1698 (C=O), 1282, 1088 (C=O) cm-1; 1H NMR (DMSO-d6, 400 MHz) δ:
12.02 (s, 1 H, NH), 7.40-6.95(m, 4 H, ArH), 4.82-4.76 (m, 2 H, CH), 4.22-4.16 (m, 1 H, CH), 3.74 (s, 3 H,
CH3); Anal. Calcd for C14H11N3O3: C, 62.45; H, 4.12; N, 15.61. Found: C, 62.22; H, 4.15; N, 15.52.
4-Methyl-4-phenyl-3,5-dicyano-2,6-piperidinedione (4j) : mp 290-291oC; IR (KBr) ν: 3304 (NH),
2238 (CN), 1746, 1706 (C=O) cm-1; 1H NMR (DMSO-d6, 400 MHz) δ: 12.15 (s, 1 H, NH), 7.44-7.20(m,
5 H, ArH), 4.82 (s, 2 H, CH), 1.46 (s, 3 H, CH3); Anal. Calcd for C14H11N3O2: C, 66.40; H, 4.38; N, 16.59.
Found: C, 66.20; H, 4.27; N, 16.40.
ACKNOWLEDGEMENTS
We are pleased to acknowledge the financial support from Xinxiang Medical College (No.
04GXLP05).
REFERENCES AND NOTES
1. S. A. El Batran, A. E. N. Osman, M. M. Ismail, and A. M. El Sayed, Inflammopharmacology, 2006,
14, 62.
2. (a) G. M. Ye, Q. Y. Wu, X. J. Huang, Y. Y. Jiang, H. L. Liao, and S. C. Yu, Dier Junyi Daxue
Xuebao, 2005, 26, 223; ( b) R.W. Holder, J. P. Daub, W. E. Baker, R. H. Gilbert, and N. A. Graf, J.
Org. Chem., 1982, 47, 1445; (c) R. F. Brown and N. M. Van Gulick, J. Am. Chem. Soc., 1955, 77,
1089; (d) E. B. Reid and T. E. Gompf, J. Org. Chem., 1953, 18, 661; (e) Y. Xu, Z. H. Zhu, Z. J.
Tong, D. M. Peng, and L. X. Duan, Zhongguo Yiyao Gongye Zazhi, 1993, 24, 49; (f) Z. Y. Peng and